Tokyo, Nov. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059863) titled 'Development to localize endocrine tumors using cell-free DNA obtained from tumor venous blood sampling' on Nov. 23.
Study Type:
Observational
Primary Sponsor:
Institute - Nagasaki University Hospital
Condition:
Condition - Primary aldsteronism,or Cushing disease
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - In venous sampling for diagnosing the localization of endocrine tumors including primary aldosteronism and Cushing's disease, we mesure circulating tumor DNA (cell-free DNA: cfDNA) in addition to measuring hormone levels to improve the accuracy of tumor loca...